Abridge Overview
Pro stress-test →Abridge transforms doctor-patient conversations into structured clinical documentation through an AI system that records the conversation and within minutes produces a complete medical note in SOAP format (Subjective, Objective, Assessment, Plan). The company currently has over 150 health systems using its generative AI technology to improve the capture of more than 50 million clinical conversations across 55 specialties and 28 languages.
Strategic Profile
Pro stress-test →Abridge's primary go-to-market advantage stems from giving Epic both an equity stake and ongoing revenue share, securing preferential access to 38% of all hospital networks that use Epic, positioning them as the default AI scribe in Epic-owned systems like Mayo, Kaiser, and Duke. The company plans to use funding as of 2026-07-27 to transform clinical documentation and revenue cycle workflows by scaling its platform to provide revenue cycle intelligence earlier in clinical conversations and eliminate the need for manual and delayed coordination between clinicians and billing teams.
Competitive Landscape
Pro stress-test →Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry and integration with Epic Systems, the dominant health record software. Top competitors include Tandem Health, voize, and DeepScribe. Competitors like Nuance and Augmedix offer more comprehensive solutions by incorporating medical coding support and covering a wider range of specialties.
Industry Context
Abridge operates in Healthcare IT Services.
Key facts
Founded: 2018 · Headquarters: Pittsburgh, US · Employees: 200+ · Revenue: Estimated $40M-$60M based on $117M contracted annual recurring revenue (Q1 2025); actual revenue recognition pending · Market cap: N/A